QSS
ITCI

Quantitative Systematic Strategies’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quantitative Systematic Strategies’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,855
Closed -$279K – 766
2020
Q3 		$279K Buy
+10,855
New +$248K 0.05% 450
2016
Q3 		– Sell
-22,102
Closed -$827K – 518
2016
Q2 		$827K Buy
+22,102
New +$794K 0.39% 94
2016
Q1 		– Sell
-5,458
Closed -$301K – 806
2015
Q4 		$301K Buy
+5,458
New +$275K 0.08% 772

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Quantitative Systematic Strategies's ITCI Position: Q4 2020 in Review

Quantitative Systematic Strategies sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2020, closing a stake of 10,855 shares — an estimated $279K sold.

Quantitative Systematic Strategies first reported a position in ITCI in Q4 2015 and held it in 3 quarters. The position peaked at $827K in Q2 2016. 178 funds tracked by Wall St. Rank hold ITCI as of Q4 2020.

  • Quantitative Systematic Strategies reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 10,855 Intra-Cellular Therapies Inc. shares in Q4 2020, an estimated $279K.
  • Quantitative Systematic Strategies first reported a position in Intra-Cellular Therapies Inc. in Q4 2015 and held it in 3 quarters.
  • Quantitative Systematic Strategies's Intra-Cellular Therapies Inc. position peaked at $827K in Q2 2016.
  • 178 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2020, filed 9 Feb 2021.